Literature DB >> 21993161

Assessment of population-level effect of Avahan, an HIV-prevention initiative in India.

Marie Ng1, Emmanuela Gakidou, Alison Levin-Rector, Ajay Khera, Christopher J L Murray, Lalit Dandona.   

Abstract

BACKGROUND: The aim of Avahan, the India AIDS Initiative, was to reduce HIV transmission in the general population through large-scale prevention interventions focused on high-risk groups. It was launched in 2003 in six states with a total population of 300 million and a high HIV burden. We assessed the population-level effect of the first phase of Avahan (2003-08).
METHODS: Population prevalence was estimated by use of adjustment factors from the national HIV sentinel surveillance data obtained annually from antenatal clinics. A mixed-effects multilevel regression model was developed to estimate the association between intervention intensity and population HIV prevalence trends, taking into account differences in the underlying epidemic trends in states and other potential confounders, and to estimate the number of HIV infections averted with Avahan.
FINDINGS: 80 (61%) of 131 districts in the six Avahan states received funding from Avahan for HIV prevention, as the only or shared source. Greater intensity of Avahan, measured as amount of grant per HIV population (medians US$24-432 in the six states), was significantly associated with lower HIV prevalence in Andhra Pradesh (p=0·004), Karnataka (p=0·004), and Maharashtra (p=0·008) states; this association was not significant in Tamil Nadu (p=0·06), Manipur (p=0·62), and Nagaland (p=0·67). Overall, we estimated that 100,178 HIV infections (95% CI 25,897-207,713) were averted at the population level from 2003 up to 2008 as a result of Avahan.
INTERPRETATION: The results of our analysis suggest that Avahan had a beneficial effect in reducing HIV prevalence at the population level over 5 years of programme implementation in some of the states. With stagnating funding for HIV prevention globally, our findings support investment in well planned and managed HIV prevention programmes in low-income and middle-income countries. FUNDING: Bill & Melinda Gates Foundation. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21993161     DOI: 10.1016/S0140-6736(11)61390-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  Decline in the prevalence of HIV and sexually transmitted infections among female sex workers in Benin over 15 years of targeted interventions.

Authors:  Luc Béhanzin; Souleymane Diabaté; Isaac Minani; Marie-Claude Boily; Annie-Claude Labbé; Clément Ahoussinou; Séverin Anagonou; Djimon M Zannou; Catherine M Lowndes; Michel Alary
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

Review 2.  Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?

Authors:  Ann M Dennis; Joshua T Herbeck; Andrew L Brown; Paul Kellam; Tulio de Oliveira; Deenan Pillay; Christophe Fraser; Myron S Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

3.  Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study.

Authors:  Sheldon Paul Stone; Christopher Fuller; Joan Savage; Barry Cookson; Andrew Hayward; Ben Cooper; Georgia Duckworth; Susan Michie; Miranda Murray; Annette Jeanes; J Roberts; Louise Teare; Andre Charlett
Journal:  BMJ       Date:  2012-05-03

4.  Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.

Authors:  Kartik K Venkatesh; Jessica E Becker; Nagalingeswaran Kumarasamy; Yoriko M Nakamura; Kenneth H Mayer; Elena Losina; Soumya Swaminathan; Timothy P Flanigan; Rochelle P Walensky; Kenneth A Freedberg
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

5.  Female sex work interventions and changes in HIV and syphilis infection risks from 2003 to 2008 in India: a repeated cross-sectional study.

Authors:  Paul Arora; Nico J D Nagelkerke; Rahim Moineddin; Madhulekha Bhattacharya; Prabhat Jha
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  Navigating the swampy lowland: a framework for evaluating the effect of community mobilisation in female sex workers in Avahan, the India AIDS Initiative.

Authors:  Christine Galavotti; Tisha Wheeler; Anne Sebert Kuhlmann; Niranjan Saggurti; Pradeep Narayanan; Usha Kiran; Gina Dallabetta
Journal:  J Epidemiol Community Health       Date:  2012-07-03       Impact factor: 3.710

7.  Evaluating AVAHAN's design, implementation and impact: lessons learned for the HIV Prevention Community.

Authors:  Marie Laga; Bea Vuylsteke
Journal:  BMC Public Health       Date:  2011-12-29       Impact factor: 3.295

8.  Pragati: an empowerment programme for female sex workers in Bangalore, India.

Authors:  Sjoerd M Euser; Dennis Souverein; Pushpalatha Rama Narayana Gowda; Chandra Shekhar Gowda; Diana Grootendorst; Rajendra Ramaiah; Snehal Barot; Sunil Kumar; Françoise Jenniskens; Shiv Kumar; Jeroen W Den Boer
Journal:  Glob Health Action       Date:  2012-11-27       Impact factor: 2.640

9.  An assessment of a large-scale HIV prevention programme for high-risk men who have sex with men and transgenders in Andhra Pradesh, India: using data from routine programme monitoring and repeated cross-sectional surveys.

Authors:  Prabuddhagopal Goswami; Hari Kumar Rachakulla; Lakshmi Ramakrishnan; Shajan Mathew; Shreena Ramanathan; Bitra George; Rajatashuvra Adhikary; Venkaiah Kodavalla; Hemalatha Rajkumar; Ramesh S Paranjape; G N V Brahmam
Journal:  BMJ Open       Date:  2013-04-08       Impact factor: 2.692

10.  Positive impact of a large-scale HIV prevention programme among female sex workers and clients in South India.

Authors:  Marie-Claude Boily; Michael Pickles; Catherine M Lowndes; Banadakoppa M Ramesh; Reynold Washington; Stephen Moses; Kathleen N Deering; Kate M Mitchell; Sushena Reza-Paul; James Blanchard; Anna Vassall; Michel Alary; Peter Vickerman
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.